Drug Approval | November 10, 2025
Johnson & Johnson gets FDA nod for new depression treatment
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Experts urge early detection & better access to care
Subscribe To Our Newsletter & Stay Updated
